23:30 Imprimis Pharma up 15% - Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY)
Thinly traded Imprimis Pharmaceuticals (IMMY +15.2%) is the latest tiny biotech/drugmaker to spike. Shares are up on more than 50% higher volume, albeit on turnover of only 245K.
The company uses compounding pharmacies to formulate and distribute its offerings, focused on ophthalmic uses.
At the end June it had $4.2M in cash and equivalents. Operations generated $400K in cash in H1.
Q2 sales were $10.4M, up 53% from a year ago.
Subscribe for full text news in your inbox
Copyright © 2013-2018 www.meiguwiki.com All Rights Reserved